M. Mosca (Pisa), R. Perricone (Roma) - Sir

More documents

Recommendations

Info

110 A. Doria et al. 31. Ghirardello A, Doria A, Zampieri S, Gerli R, Rapizzi E, Gambari PF. Anti-ribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: their specificity for SLE and association with the IgG anticardiolipin antibodies. Ann Rheum Dis 2000; 59: 975-81. 32. Briani C, Lucchetta M, Ghirardello A, et al. Neurolupus is associated with anti-ribosomal P protein antibodies: An inception cohort study. J Autoimmun 2009; 32: 79-84. 33. Ghirardello A, Caponi L, Franceschini F, Zampieri S, Gambari PF, Doria A. Diagnostic tests for antiribosomal P protein antibodies: a comparative evaluation of immunoblotting and ELISA assays. J Autoimmun 2002; 19: 71-7. 34. Karassa FB., Afeltra A, Ambrozic A, et al. Accuracy of Anti-Ribosomal P Protein Antibody Testing for Diagnosis of Neuropsychiatric Systemic Lupus Erythematosus: An International Meta-Analysis. Arthritis Rheum 2006; 54: 312-24. 35. Lu JH, Teh BK, Wang L, et al. The classical and regulatory functions of C1q in immunity and autoimmunity. Cell Mol Immunol 2008; 5: 9-21. 36. Botto M, Kirschfink M, Macor P, Pickering MC, Würzner R, Tedesco F. Complement in human diseases: Lessons from complement deficiencies. Mol Immunol 2009; 46: 2774-83. 37. Bigler C, Schaller M, Perahud I, Osthoff M, Trendelenburg M. Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells. J Immunol. 2009; 183: 3512-21. 38. Vidalino L, Doria A, Quarta S, Zen M, Gatta A, Pontisso P. SERPINB3, apoptosis and autoimmunity. Autoimmun Rev. 2009 Mar 27. [Epub ahead of print]. 39. Shoenfeld Y, Szyper-Kravitz M, Witte T, Doria A, et al. Autoantibodies against protective molecules-C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1: prevalence in systemic lupus erythematosus. Ann N Y Acad Sci 2007; 1108: 227-39. 40. Marto N, Bertolaccini ML, Calabuig E, Hughes GR, Khamashta MA. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus. Ann Rheum Dis. 2005; 64: 444-8. 41. Bijl M, Reefman E, Horst G, Limburg PC, Kallenberg CG. Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement. Ann Rheum Dis. 2006; 65: 57-63.
MALATTIA RESIDUA: TRA ATTIVITÀ E DANNO Moderatori: S. Bombardieri (Pisa), F. Trotta (Ferrara) – Artrite reumatoide: malattia residua tra attività e danno G. Ferraccioli (Roma) – Lupus eritematoso sistemico G. Valesini (Roma) – Sclerosi sistemica. Malattia residua: fra attività e danno G. Valentini (Napoli) – Polymyositis N. Pipitone (Reggio Emilia)
Page 1 and 2: COMUNICAZIONI SUL LUPUS Moderatori:
Page 3 and 4: Comunicazioni 101 QUALITÀ DI VITA
Page 5 and 6: Comunicazioni 103 INEFFICACIA DELLA
Page 7 and 8: LETTURA Moderatore: P. Meroni (Mila
Page 9 and 10: Diagnosi precoce nel LES 107 potreb
Page 11: Diagnosi precoce nel LES 109 in par
Page 15 and 16: Artrite reumatoide: malattia residu
Page 17 and 18: LUPUS ERITEMATOSO SISTEMICO G. VALE
Page 19 and 20: La sclerosi sistemica. Malattia res
Page 21 and 22: Polymyositis 119 flammatory infiltr
Page 23: Polymyositis 121 myositis, polymyos
Page 26 and 27: DEFINIZIONE E CLASSIFICAZIONE DELLE
Page 28 and 29: 126 L. Punzi et al. gruppo della MA
Page 30 and 31: AUTOINFLAMMATORY DISEASES M. GALEAZ
Page 32 and 33: ARTRITE IDIOPATICA GIOVANILE SISTEM
Page 34 and 35: 132 A. Martini, C. Malattia 5. Gatt
Page 36 and 37: 134 Comunicazioni po di pazienti co
Page 38 and 39: 136 Comunicazioni IL COMPLEMENTO: U
Page 40 and 41: 138 Comunicazioni DETECTION OF IGG/
Page 42: 140 Comunicazioni ANTICORPI ANTIFOS

M. Mosca (Pisa), R. Perricone (Roma) - Sir

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?